GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 34 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,498 | +131.0% | 300,697 | +198.9% | 0.00% | – |
| Q2 2023 | $31,386 | -43.3% | 100,594 | +0.0% | 0.00% | – |
| Q1 2023 | $55,309 | -37.9% | 100,562 | +0.0% | 0.00% | – |
| Q4 2022 | $89,066 | +8806.6% | 100,560 | +18317.6% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 546 | -7.5% | 0.00% | – |
| Q2 2022 | $2,000 | -97.7% | 590 | -98.0% | 0.00% | – |
| Q1 2022 | $87,000 | +171.9% | 30,237 | +183.9% | 0.00% | – |
| Q4 2021 | $32,000 | +146.2% | 10,649 | +498.9% | 0.00% | – |
| Q3 2021 | $13,000 | +116.7% | 1,778 | +344.5% | 0.00% | – |
| Q2 2021 | $6,000 | +500.0% | 400 | +236.1% | 0.00% | – |
| Q1 2021 | $1,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crumly & Associates Inc. | 32,163 | $93,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 20,075 | $58,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,260 | $81,000 | 0.00% |
| Sigma Planning Corp | 21,400 | $62,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 30,000 | $86,000 | 0.00% |
| Gordian Capital Singapore Pte Ltd | 35,000 | $3,000 | 0.00% |
| Welch Group, LLC | 10,000 | $29,000 | 0.00% |
| Renaissance Technologies | 186,300 | $537,000 | 0.00% |
| BRIGHTON JONES LLC | 11,012 | $32,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 24 | $0 | 0.00% |